Ensuring EmblemHealth 21st Century Cures Act Compliance in Prior Authorization
Navigating the complexities of prior authorization requires a clear understanding of regulatory mandates. For providers working with EmblemHealth, ensuring EmblemHealth 21st Century Cures Act compliance is critical for efficient operations and patient access.
The 21st Century Cures Act introduces significant requirements for health plans, directly impacting how prior authorizations are managed. Revenue cycle directors and prior authorization coordinators must understand these federal mandates to optimize workflows and maintain compliance when engaging with payers like EmblemHealth, particularly given their role as a major commercial and Medicaid insurer in New York.
The 21st Century Cures Act: Payer Obligations for Prior Authorization
The 21st Century Cures Act, through its Interoperability and Patient Access Final Rule (CMS-9115-F) and the more recent Prior Authorization Final Rule (CMS-0057-F), establishes federal requirements for health plans regarding patient data access, interoperability, and prior authorization processes. These mandates aim to enhance transparency, streamline administrative burdens, and improve the exchange of health information, directly influencing how payers like EmblemHealth manage their prior authorization operations.
EmblemHealth and Cures Act Mandates
As a prominent New York-based commercial insurer and Medicaid plan, EmblemHealth is subject to the provisions of the 21st Century Cures Act. This includes adherence to requirements for electronic prior authorization (ePA), enhanced data exchange capabilities, and greater transparency around prior authorization decisions. Providers engaging with EmblemHealth should anticipate and prepare for these evolving digital requirements, especially for their Medicaid lines of business which fall under the explicit scope of CMS-0057-F.
Key Cures Act Requirements Impacting EmblemHealth Prior Authorization
- **Electronic Prior Authorization (ePA):** Mandates for certain payers, including Medicaid plans, to implement and maintain an electronic prior authorization API, supporting the X12 278 transaction and potentially FHIR-based standards.
- **Patient Access API:** Requires payers to make claims and encounter data, including prior authorization decisions, available to patients via a secure API using SMART on FHIR standards.
- **Provider Access API:** For applicable plans, an API that allows providers to access patient claims, encounters, and prior authorization status.
- **Payer-to-Payer Data Exchange:** Facilitates the sharing of patient data, including prior authorization information, when a patient moves between health plans.
- **Transparency and Timeliness:** Requirements for shorter turnaround times for prior authorization decisions and public reporting of PA metrics.
Operationalizing Compliance with EmblemHealth's Evolving PA Landscape
For providers, achieving EmblemHealth 21st Century Cures Act compliance means adapting to new electronic submission methods and leveraging data exchange capabilities. Platforms like Klivira integrate directly with EMRs and payer portals, including those used by EmblemHealth, to automate the submission and tracking of prior authorizations. This includes supporting standards like X12 278 and preparing for FHIR-based ePA through initiatives like Da Vinci PAS Implementation Guides.
Enhancing Interoperability for Efficient Prior Authorization
The Cures Act pushes for greater interoperability, which directly benefits providers by reducing manual PA burdens. By automating the process and leveraging the APIs mandated by the Cures Act, providers can improve the speed and accuracy of prior authorization submissions to EmblemHealth, ultimately leading to faster patient access to care and improved revenue cycle performance. Consider discussing these interoperability benefits with your IT and compliance teams.
Frequently asked questions
What is the primary impact of the 21st Century Cures Act on EmblemHealth's prior authorization processes?
The Cures Act primarily mandates greater electronic interoperability, transparency, and efficiency in prior authorization. For EmblemHealth, this means implementing APIs for patient and provider data access, supporting electronic prior authorization (ePA), and adhering to stricter turnaround times for PA decisions, particularly for their Medicaid lines of business.
Does the Cures Act mandate electronic prior authorization for EmblemHealth?
Yes, specifically for EmblemHealth's Medicaid managed care plans, the Prior Authorization Final Rule (CMS-0057-F) mandates the implementation of an electronic prior authorization (ePA) API. While commercial plans have similar pressures, the mandate is explicit for government-sponsored programs.
How does the Cures Act affect data exchange between providers and EmblemHealth?
The Cures Act requires EmblemHealth to establish APIs (Patient Access API, Provider Access API) that enable the secure electronic exchange of patient data, including prior authorization status. This facilitates more seamless, automated data flow between providers and the payer, reducing reliance on faxes or phone calls.
What are the transparency requirements under the Cures Act for payers like EmblemHealth?
The Cures Act requires EmblemHealth to make certain prior authorization metrics publicly available. Additionally, through the Patient Access API, patients gain more direct access to their prior authorization decisions and status, enhancing transparency for all stakeholders.
How can Klivira assist with EmblemHealth 21st Century Cures Act compliance?
Klivira automates prior authorization workflows by integrating directly with EMRs and payer portals, including those used by EmblemHealth. This automation supports electronic submission requirements, tracks PA status, and helps providers leverage the interoperability mandates of the Cures Act to streamline their PA processes.
Related coverage
Ready to stay compliant with this rule?
See how Klivira automates prior authorizations for your team.
Request a demo